[Methods for increasing the immunogenicity of vaccines]

[Methods for increasing the immunogenicity of vaccines] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Methods for increasing the immunogenicity of vaccines] Abstract Text:

In the past years, enormous efforts have been undertaken to develop vaccine strategies against cancer. The aim is to have the immune system generate what are called killer cells that can specifically recognize the tumor. The surface of tumor cells contains MHC/HLA antigens which present short-chain peptides of tumor specific antigens. A large number of these oligopeptide antigens have been characterized in recent years. They are now available for use as tumor-specific vaccines. The problem is, however, that the immune response of producing T killer cells is very inefficient when these oligopeptide antigens are injected. As the physiological function of these killer cells virus-infected cells, a process associated with substantial tissue damage, the immune system has learned to use these killer cells with reticence over the course of evolution, in other words, when the life of the host is threatened. This does not happen until pathogens start to spread via lymphogenous or hematogenous pathways. And then it takes a certain amount of time after the invader is present for replication to take place. Since the oligopeptide antigens used as vaccines have a very short half-life in the tissue, not enough of them get to the lymph nodes and stay there for enough time to efficiently induce an immune response. Using a mouse model, we were able to show that the efficiency of the vaccine can be increased a million-fold by directly injecting the vaccine into a lymph node or the spleen which imitates lymphogenous or hematogenous spread. The efficiency of the "inactivated vaccine" can be enhanced even more by continuous administration of the vaccine over several days, simulating an especially dangerous virus replication. The evidence gathered in this mouse model was transferred to a clinical trial. The melanoma-specific inactivated vaccine is infused directly into a lymph node of tumor patients. The infusion is continued for several days. Booster vaccines are given every two weeks.

[Methods for increasing the immunogenicity of vaccines] Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[Methods for increasing the immunogenicity of vaccines] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Praxis

VOLUME: 89

Page Numbers: 1477-84

Journal Abbreviation:

ISSN: 1661-8157

DAY: 14

MONTH: Sep

YEAR: 2000

[Methods for increasing the immunogenicity of vaccines] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 101468093

[Methods for increasing the immunogenicity of vaccines] Keywords Mesh Terms:

KEYWORDS: Vaccines, Subunit

MESH TERMS: immunology

Chemical & Substance for Abstract: [Methods for increasing the immunogenicity of vaccines] Information

Substance Name: Vaccines, Subunit

Registry Number: 0

Grant and Affiliation Information for [Methods for increasing the immunogenicity of vaccines]

AFFILIATION: Dermatologische Klinik, UniversitätsSpital Zürich. tkuendig@derm.unizh.ch

Country: SWITZERLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Praxis (Bern 1994)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Methods for increasing the immunogenicity of vaccines Related Publications

• Antigen kinetics determines immune reactivity.
• Chiral N-heterocyclic carbene ligands for asymmetric catalytic oxindole synthesis.
• Iron and ruthenium Lewis acid catalyzed asymmetric 1,3-dipolar cycloaddition reactions between nitrones and enals.
• Medication with antihistamines impairs allergen-specific immunotherapy in mice.
• Microbial multidrug resistance.
• The control of myometrial functions during parturition with Abeta(2) - mimeticcompound, Planipart(R).
• [Existential analytical psychotherapy and Christian belief]
• [Inactivation of thiamine by substance K and other hemin compounds as well as by different iron salts]
• [Methods for increasing the immunogenicity of vaccines]
• [Therapy of chronic urticaria and recurrent Quincke edema]